Bioengineered directoids enable in vitro probing of information flow between human brain regions

Organoid technologies

28bio launches CNS-3D myelinated organoids to predict therapeutic efficacy

Product Launches

Mimetas launches OrganoAccess™ perfusable vascular bed for advanced 3D tissue modeling

Product Launches

Inventia Life Science launches RASTRUM Validated Solutions to accelerate decision-grade data

Product Launches

InSphero launches 3D InSight™ gastrointestinal toxicity screening platform

Product Launches

InSphero expands its high-content imaging capabilities with acquisition of PhenoVista Biosciences

M&A Activity

Axol Bioscience acquires ophthalmology business from Newcells Biotech

M&A Activity

FDA releases draft guidance on alternatives to animal testing in drug development

Regulatory Modernizations

European Commission publishes its roadmap towards phasing out animal testing

Regulatory Modernizations

MHRA announces new regulatory action to support the phase‑out of animal testing

Regulatory Modernizations

Human sympathetic ganglion organoids support investigation of sympathetic innervation of target organs

Organoid technologies

Autologous human tumor-immune organoid model for patient-specific prediction of response to immunotherapy

Organoid technologies